[18f]f-resca-rb14
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 12, 2024 (NCT06715839)
Timeline
No events for the selected filters.
Mechanism of action
- Receptor protein-tyrosine kinase erbB-2Radiopharmaceutical
ERBB2 radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06715826 | N/A | Sep 21, 2024 | Jiao Tong University |
| NCT06715839 | N/A | Sep 12, 2024 | Jiao Tong University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiao Tong University | Academic/Hospital | 2 | 2 | 1 | 2024 |
1 organizations
Page 1 / 1